aTyr Pharma's Series D Round

aTyr Pharma raised a round of funding on July 29, 2013.

aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered…

Articles about aTyr Pharma's Series D Round: